Skip to main content
Figure 2 | BMC Immunology

Figure 2

From: Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation

Figure 2

Effects of beta-escin at different time points of pre-treatment in the murine PCA model. SKH1-mice were injected with beta-escin (3 mg/kg) at different time points prior PCA induction as described in Fig. 1. For each mouse the mean of 6 spots was calculated. Based on these values the mean ± SEM was determined for 4 - 12 (escin) or 21 (vehicle) mice per treatment group and normalized to the vehicle control group. Significant differences between the treatment groups and the vehicle group are indicated with: ** p < 0.01 and *** p < 0.001.

Back to article page